| Dr Rory Williams, MD | |
|
1064 Broadway Ave, Bartow, FL 33830-3300 | |
| (863) 519-9797 | |
| (863) 533-8723 |
| Full Name | Dr Rory Williams |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 1064 Broadway Ave, Bartow, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043522915 | NPI | - | NPPES |
| 201198680 | Medicaid | IN | |
| 000000854287 | Other | IN | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 125.058880 (Illinois) | Secondary |
| 207Q00000X | Family Medicine | ME120589 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pinnacle Home Care | Orlando, FL | Home health agency |
| Adventhealth Orlando | Orlando, FL | Hospital |
| Entity Name | Mid Fl Hospital Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588675912 PECOS PAC ID: 5092628107 Enrollment ID: O20031106000013 |
News Archive
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.
A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.
Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 8 days ago
| Entity Name | Cogent Healthcare Of Pensacola Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346287182 PECOS PAC ID: 1153226766 Enrollment ID: O20031205000170 |
News Archive
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.
A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.
Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 8 days ago
| Entity Name | Central Florida Inpatient Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649228859 PECOS PAC ID: 7911805254 Enrollment ID: O20031223000824 |
News Archive
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.
A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.
Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 8 days ago
| Entity Name | Greater Orlando Hospitalists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922028208 PECOS PAC ID: 2769479344 Enrollment ID: O20040427000340 |
News Archive
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.
A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.
Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 8 days ago
| Entity Name | Inpatient Consultants Of Florida, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396795597 PECOS PAC ID: 4789614785 Enrollment ID: O20050819000018 |
News Archive
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.
A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.
Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 8 days ago
| Entity Name | Raypar Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356374466 PECOS PAC ID: 5092817551 Enrollment ID: O20070301000381 |
News Archive
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.
A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.
Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 8 days ago
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20180208000317 |
News Archive
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.
A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.
Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 8 days ago
| Entity Name | Liberty Physicians Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376181446 PECOS PAC ID: 3870920853 Enrollment ID: O20200304001002 |
News Archive
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.
A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.
Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 8 days ago
| Entity Name | Value Based Inpatient Specialist |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790260388 PECOS PAC ID: 9436589553 Enrollment ID: O20200413003448 |
News Archive
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.
A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.
Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rory Williams, MD 1064 N Broadway Ave, Bartow, FL 33830-3301 Ph: (863) 519-9797 | Dr Rory Williams, MD 1064 Broadway Ave, Bartow, FL 33830-3300 Ph: (863) 519-9797 |
News Archive
Diabetes strongly increases the risk of heart failure in all ethnic groups, but early effects of diabetes on the heart may differ depending on whether the subjects are white, African-American, Hispanic or Chinese.
Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.
A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.
Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.
KemPharm, Inc. today announced that KP106, its clinical candidate for Attention Deficit/Hyperactivity Disorder, will be formulated and developed in an oral film dosage form pursuant to an exclusive collaboration agreement with MonoSol Rx relating to the development, commercialization and manufacture of KP106.
› Verified 8 days ago
Billy Sana Kong, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1255 Brice Blvd, Bartow, FL 33830 Phone: 863-519-8233 Fax: 863-519-8304 | |
Maria Karina Solorzano-klapprott, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2250 Osprey Blvd, Suite 100, Bartow, FL 33830 Phone: 863-680-7190 Fax: 866-264-8519 | |
Terrence Delikat, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1350 E Main St Ste C-2, Bartow, FL 33830 Phone: 863-537-6151 Fax: 863-537-7146 | |
Richard Francis Sweeney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2250 Osprey Blvd, Ste 100, Bartow, FL 33830 Phone: 863-680-7190 Fax: 866-264-8519 | |
Kristina M. Hair, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2250 Osprey Blvd Ste 100, Bartow, FL 33830 Phone: 863-680-7190 Fax: 866-264-8519 |